Decheng Capital LLC Bio N Tech Se Transaction History
Decheng Capital LLC
- $466 Billion
- Q4 2024
A detailed history of Decheng Capital LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Decheng Capital LLC holds 40,000 shares of BNTX stock, worth $4.91 Million. This represents 0.98% of its overall portfolio holdings.
Number of Shares
40,000Holding current value
$4.91 Million% of portfolio
0.98%Shares
1 transactions
Others Institutions Holding BNTX
# of Institutions
362Shares Held
39.6MCall Options Held
3.01MPut Options Held
2.01M-
Baillie Gifford & CO8.22MShares$1.01 Billion0.74% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$541 Million2.03% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$527 Million0.39% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$233 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$222 Million1.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $29.8B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...